The generation born on the cusp of the technology boom is turning to social media for help in the kitchen. Through their TikTok and Instagram feeds, people like University of Arizona junior Lilly Fine ...

So what does this Wall Street analyst like about Lilly? Yesterday, Eli Lilly announced it will spend $7 billion to acquire privately held Kelonia Therapeutics and its KLN-1010 CAR-T gene therapy drug ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

Add Yahoo as a preferred source to see more of our stories on Google. April 19 (Reuters) - U.S. drugmaker Eli Lilly (LLY) is in advanced talks to acquire biotech firm Kelonia ‌Therapeutics for more ...

Eli Lilly (LLY) on Monday announced an agreement to acquire Kelonia Therapeutics, a privately held cancer drug developer, in a deal worth up to $7B in cash, confirming a prior report from The Wall ...

Eli Lilly & Co.’s new weight-loss pill Foundayo has gotten off to a sluggish start, according to new prescription data, an early sign of the challenge the drugmaker will have as it tries to catch up ...

Eli Lilly (LLY) is in advanced negotiations to acquire Kelonia Therapeutics in a transaction valued at more than $2 billion, The Wall Street Journal reported Sunday, citing people familiar with the ...

Eli Lilly LLY is set to release its first-quarter 2026 earnings report on April 30. Here’s Morningstar’s take on what to look for in Lilly’s earnings and the outlook for its stock. With its 3-star ...

Novartis, Amgen and Eli Lilly are among the pharmaceutical companies developing drugs to lower levels of a particularly bad form of cholesterol called Lp(a) and potentially prevent heart attacks. Lp(a ...

Pharmaceutical powerhouse Eli Lilly & Co. will buy Boston gene therapy maker Kelonia Therapeutics for at least $3.25 billion, the companies announced Monday. The acquisition will grant ...

Kelonia specializes in 'in vivo' CAR-T therapies for cancer Deal includes $3.25 bln upfront and milestone payments Deal price reflects strong data and sector competition - analyst April 20 (Reuters) - ...

Eli Lilly struck a deal to acquire Kelonia Therapeutics for $3.25 billion, the companies said Monday. The deal price could reach as much as $7 billion if Kelonia reaches certain clinical, regulatory ...